Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630821 · ClinicalTrials.gov registry record · NA
Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04630821 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 6 participants.
The verdict
NCT04630821, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of the pilot study is to determine compliance, acceptability, and feasibility of using topical sodium hypochlorite to ameliorate or reduce radiation dermatitis, and to collect preliminary data and estimates for planning a larger efficacy study. This 3-week single-arm pilot study will collect information on subject treatment compliance and feedback from subjects (and nurses/subject's treating oncologist) on the acceptability of the use of the treatment. We will also collect data on Common Terminology Criteria for Adverse Events and patient reported outcomes measured using the pain and pruritus PROMIS short-form tools and patient reported outcomes, measured using the Dermatology Life Quality Index (DLQI) tool.
Interventions
- OTHER Dilute Sodium Hypochlorite solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04630821
The ClinicalTrials.gov registry entry for NCT04630821 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dilute Sodium Hypochlorite solution is the first listed.
NCT04630821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04630821 about?
NCT04630821 is a clinical study titled "Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis". The objective of the pilot study is to determine compliance, acceptability, and feasibility of using topical sodium hypochlorite to ameliorate or reduce radiation dermatitis, and to collect preliminary data and estimates for planning a larger efficacy study. This 3-week single-arm pilot study will ...
What is the current status of trial NCT04630821?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-08. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT04630821?
The interventions under investigation include: Dilute Sodium Hypochlorite solution (OTHER).
Who is sponsoring clinical trial NCT04630821?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.